Th17 cells promote tumor immunity via the induction of CXCL9 and CXCL10, key chemokines that promote the infiltration and activation of cytotoxic NK cells and CD8+ T cells within the TIM [85]. The gene discussed is CXCL9; the disease is neoplasm.